CD44 and breast carcinoma: A recent study provided evidential support that correlated with our results on hsa-miR-29a/b-3p, which was significantly upregulated in the ER- fractions of MCF7 cells and also in CD44+/CD24− breast cancer stem cells (BCSCs) [49].